Sensex and Nifty Edge Lower Amid Trump’s Pharma & BRICS Tariff Threats
Sensex and Nifty open flat amid Trump’s looming pharma and BRICS tariffs. Pharma stocks drop while investors weigh India‑USA trade risks. Market sectors cautious
image for illustrative purpose
Indian benchmark indices S&P BSE Sensex and NSE’s Nifty 50 opened Wednesday broadly flat, feeling the impact of U.S. President Donald Trump’s latest tariff threats targeting pharmaceuticals and BRICS nations—moves that rattled investors.
By 9:15 a.m. IST, the Sensex had slipped about 0.1% to 83,626, while the Nifty 50 edged lower by 0.03% to 25,514 points. Among the 13 major NSE sectors, seven were trading in the red.
Pharma shares were particularly impacted, with the pharmaceutical index down approximately 0.3%, following Trump’s warning of potential 200% tariffs on U.S.-bound drug imports. The U.S. is crucial for India’s $9 billion pharma export industry, accounting for around one-third of total exports.
Further downside risk emerged when Trump also flagged a future 10% tariff on imports from BRICS nations—including India—which compounded market unease.
In broader trading, small‑cap and mid‑cap segments were stable, suggesting a cautious market tone as investors awaited clarity on Trump’s tariff plans and potential trade-negotiation moves.Sensex and Nifty open flat amid Trump’s looming pharma and BRICS tariffs. Pharma stocks drop while investors weigh India‑USA trade risks. Market sectors cautious.
